Today: 30 April 2026
GE Vernova stock in focus as Vietnam LNG power plant starts operations; Jan. 28 earnings next
6 January 2026
1 min read

GE Vernova stock in focus as Vietnam LNG power plant starts operations; Jan. 28 earnings next

NEW YORK, Jan 6, 2026, 2:30 PM EST — Regular session

  • Shares rose 0.4% after a sharp intraday dip, with traders watching $660 support and $700 resistance
  • GE Vernova said a 1.6-GW LNG-fired plant in Vietnam entered commercial operation using its HA-class turbines
  • The company set Jan. 28 for fourth-quarter and full-year 2025 results before the opening bell

GE Vernova Inc. shares were up 0.4% at $683.39 in afternoon trading on Tuesday after swinging between $658.96 and $684.38 earlier in the session. Traders have been watching the $660 area after the stock briefly slipped below it, with resistance near $700 after Monday’s intraday peak.

The power equipment maker said on Monday that PetroVietnam Power Corp’s Nhon Trach 3&4 plant in southern Vietnam has started commercial operations. The 1.6-gigawatt liquefied natural gas (LNG) facility — LNG is natural gas cooled into a liquid for shipping — uses GE Vernova’s 9HA.02 gas turbines in a combined-cycle setup that uses waste heat to generate extra power, and can support hydrogen co-firing, which blends hydrogen with natural gas. “Lower-carbon and highly efficient gas power generation will play a crucial role … ensuring grid stability and reliability,” said Ramesh Singaram, who leads GE Vernova’s Gas Power business in Asia Pacific. GE Vernova

In a separate release, GE Vernova said it will report fourth-quarter and full-year 2025 results on Jan. 28 before the U.S. market opens, followed by a 7:30 a.m. ET webcast led by CEO Scott Strazik and CFO Ken Parks. The date sets the next near-term catalyst for investors looking for fresh data on orders, margins and cash flow heading into 2026.

Investors will be looking for detail on order intake and profitability in Gas Power and Electrification, which supplies grid equipment such as transformers and high-voltage systems. Any change in commentary on pricing, delivery schedules and service demand will also be closely parsed.

The Vietnam project was inaugurated in December and is backed by a 25-year LNG supply agreement between PV Power and PetroVietnam Gas, POWER magazine reported. Vietnam’s updated power plan calls for more than 22 gigawatts of LNG-fueled capacity by 2030, a buildout that puts GE Vernova in direct competition with turbine suppliers such as Siemens Energy and Mitsubishi Power.

But large power projects can run into delays tied to fuel logistics, permitting and grid connections, and any slippage can push high-margin service work and cash generation to the right. With the stock prone to sharp intraday swings, a cautious tone on Jan. 28 — or signs of softer demand — could revive volatility.

U.S. stocks were modestly higher on Tuesday as investors looked ahead to key economic data that can shape interest-rate expectations. The U.S. jobs report for December is due on Friday, and December CPI is scheduled for Jan. 13; the Federal Reserve’s next policy meeting runs Jan. 27-28.

GE Vernova’s next checkpoint is the Jan. 28 results and webcast, when investors will look for 2026 guidance and updates on orders, margins and cash flow.

Stock Market Today

  • Biogen Shares Rise 6% After Q1 Earnings Beat Despite Guidance Cut
    April 29, 2026, 9:29 PM EDT. Biogen (NASDAQ: BIIB) shares rose 6% on Wednesday following its first-quarter 2026 earnings report. The biotech posted $2.48 billion in revenue, surpassing analyst expectations of $2.25 billion. Net income, excluding accounting standards (GAAP), increased 19% to over $529 million, or $3.57 per share, above forecasts of $2.95. Growth was driven by strong sales of Leqembi, for early Alzheimer's, up 74%, and the FDA-approved Skyclarys for Friedreich's ataxia. However, Biogen cut full-year adjusted net income guidance by $1 per share citing research and development charges. Revenue is expected to decline mid-single digits from 2025, excluding a pending $5.6 billion acquisition of Apellis Pharmaceuticals. Biogen's strategic shift towards high-potential therapies is underway despite cautious outlook.

Latest article

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

Soluna Holdings Stock Jumps After Sazmining Bitcoin Deal, Then SEC Resale Filing Lands

30 April 2026
Soluna Holdings filed to register the resale of about 2.46 million common shares, with no proceeds going to the company. The move follows Sazmining’s launch of a 3-megawatt Bitcoin mining operation at Soluna’s Project Dorothy 1B in West Texas. Soluna shares last traded at $1.28, up from a $1.08 Nasdaq sale price on April 28. The registered shares include 2.4 million issuable to YA II PN, LTD. via warrant exercise.
Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
IREN Limited stock slides 10% as bitcoin cools — what investors watch next
Previous Story

IREN Limited stock slides 10% as bitcoin cools — what investors watch next

Synopsys stock climbs as CES automotive push and chip rally lift SNPS shares
Next Story

Synopsys stock climbs as CES automotive push and chip rally lift SNPS shares

Go toTop